Skip to main content

Ipamorelin CJC 1295 Combination

Meaning

The Ipamorelin CJC 1295 Combination is a specific, synergistic therapeutic protocol involving the co-administration of two distinct Growth Hormone Secretagogues (GHSs): Ipamorelin and CJC-1295 (with DAC). Ipamorelin is a selective GH-releasing peptide (GHRP), while CJC-1295 is a Growth Hormone-Releasing Hormone (GHRH) analog with a long duration of action. This combination is clinically used to induce a robust, physiological increase in pulsatile growth hormone secretion, aiming to enhance anti-aging effects, improve body composition, and accelerate recovery. The combined action provides both a sustained baseline and an amplified pulse of GH release.